HomeInsightsStock Comparison

Granules India Ltd vs Influx Healthtech Ltd Stock Comparison

Granules India Ltd vs Influx Healthtech Ltd Stock Comparison

Last Updated on: Jul 05, 2025

Key Highlights

  • The Latest Trading Price of Granules India Ltd is ₹ 492.8 as of 04 Jul 15:30.
  • The P/E Ratio of Granules India Ltd changed from 10.9 on March 2020 to 25.7 on March 2024 . This represents a CAGR of 18.71% over 5 yearsThe P/E Ratio of Influx Healthtech Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Granules India Ltd changed from ₹ 3650 crore on March 2020 to ₹ 10420 crore on March 2024 . This represents a CAGR of 23.34% over 5 yearsThe Market Cap of Influx Healthtech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Granules India Ltd for the Mar '25 is ₹ 1230 crore as compare to the Dec '24 revenue of ₹ 1143 crore. This represent the growth of 7.59% The revenue of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Granules India Ltd for the Mar '25 is ₹ 285.03 crore as compare to the Dec '24 ebitda of ₹ 235.97 crore. This represent the growth of 20.79% The ebitda of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Granules India Ltd changed from ₹ 47.9 crore to ₹ 152.03 crore over 8 quarters. This represents a CAGR of 78.15% The net profit of Influx Healthtech Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Granules India Ltd changed from 5.72 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Influx Healthtech Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Granules India Ltd

  • Granules India Limited is a large-scale vertically integrated company founded in March, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD).
  • With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
  • Granules India is the preferred supplier for some of the world's leading pharma branded and generics companies.
  • The company has one of largest PFI and single site FD facilities in the world.
  • It is also home to one of the World's largest Paracetamol API facilities. Company's research center at Pragathi Nagar, Hyderabad, spread across an area of 15,000 square feet, epitomizes the company's focus on research and development.

About Influx Healthtech Ltd

  • Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
  • Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai. Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.

Granules India Ltd News Hub

News

Granules India arm receives one observation from USFDA for U.S. facility

In a regulatory filing, the company stated that the USFDA conducted a Pre-Approval Inspect...

Read more

28 Jun 2025 15:38

News

Granules India receives one observation from USFDA following inspection at Telangana facility

In a regulatory filing, the company stated that the USFDA conducted the inspection from 16...

Read more

23 Jun 2025 09:36

News

Granules India allots Equity shares

Granules India has approved the allotment of 1,00,000 equity shares in consequence of the ...

Read more

17 Jun 2025 11:30

News

Granules India announces cessation of Vice President & Head- IT

Granules India announced that Krishnamohan B., shall to be the Senior Management Personnel...

Read more

02 Jun 2025 12:46

News

Granules India to convene AGM

Granules India announced that the 34th Annual General Meeting(AGM) of the company will be ...

Read more

28 May 2025 14:10

News

Board of Granules India recommends final dividend

Granules India announced that the Board of Directors of the Company at its meeting held on...

Read more

28 May 2025 14:11

Influx Healthtech Ltd News Hub

News

NSE SME Influx Healthtech makes a strong debut

The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public of...

Read more

25 Jun 2025 11:42

SWOT Analysis Of Granules India Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Granules India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Granules India Ltd and Influx Healthtech Ltd

Which company has a larger market capitalization, Granules India Ltd or Influx Healthtech Ltd?

Market cap of Granules India Ltd is 11,957 Cr while Market cap of Influx Healthtech Ltd is 304 Cr

What are the key factors driving the stock performance of Granules India Ltd and Influx Healthtech Ltd?

The stock performance of Granules India Ltd and Influx Healthtech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Granules India Ltd and Influx Healthtech Ltd?

As of July 5, 2025, the Granules India Ltd stock price is INR ₹492.8. On the other hand, Influx Healthtech Ltd stock price is INR ₹131.35.

How do dividend payouts of Granules India Ltd and Influx Healthtech Ltd compare?

To compare the dividend payouts of Granules India Ltd and Influx Healthtech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions